David W. Kissane is a psychiatrist, psycho-oncology researcher, and palliative care physician. He is emeritus at Monash University and the University of Notre Dame Australia, a prior Chairman of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center, NY, USA, and Foundation Chair of Palliative Medicine at the University of Melbourne. His academic interests include demoralization, psychotherapy trials, communication skills training, and bereavement care. His work on demoralization (low morale, poor coping, hopelessness and pointlessness), with the validation of measurement scales and interview, has contributed to its recognition as a new diagnosis in ICD-11. His model of family-centred care in oncology prevents complicated grief; his cognitive-existential therapy prevents fear of recurrence. He has been awarded lifetime achievement awards by the International Psycho-Oncology Society, Clinical Oncology Society of Australia, and appointed a Companion of the Order of Australia.Smita C. Banerjee is an Attending Behavioral Scientist in the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, NY, USA. Her research is in cancer prevention and control, with special emphasis on the role of communication between oncology care providers and patients, and message framing for cancer risk prevention. Her research has been funded by the National Cancer Institute (NCI), National Institute on Drug Abuse (NIDA), and philanthropic organizations like T. J. Martell Foundation, Goldstein Foundation, and Geri & Me Foundation. She is currently leading an NCI-funded national multisite trial of empathic communication skills training to reduce lung cancer stigma. She has published over 100 peer-reviewed manuscripts, 15 reviews and book chapters, and presented in over 100 national and international conferences.Barry Bultz is an Emeritus Professor in Oncology and Psychiatry at the University of Calgary. He was the Founding Director of the Department of Psychosocial Oncology at the Tom Baker Cancer Centre and the inaugural Daniel Family Leadership Chair in Psychosocial Oncology at the University of Calgary. Dr. Bultz's research and clinical focus is on biopsychosocial Screening for Distress (as the 6th Vital Sign). He co-founded and served as President of the Canadian Association of Psychosocial Oncology and was an Invited Director of the American Psychosocial Oncology Society. In 2012-14 he was President of the International Psycho-Oncology Society. He has earned numerous awards including the Canadian Association of Psychosocial Oncology Award of Excellence, the Alberta Order of Excellence, and the Arthur Sutherland Award from the International Psycho-Oncology Society. He is a Fellow of the American Psychosocial Oncology Society. In 2021 Dr. Bultz was appointed an Officer of the Order of Canada.Simon Noble is a Marie Curie Professor in Supportive and Palliative Medicine in the Division of Population Medicine, Cardiff University, UK, where he is a tutor in the internationally recognised Diploma and MSc in Palliative Care. He has extensive experience in teaching communication skills within the multidisciplinary setting and a particular interest in how models of communication translate across differing cultures. His research interests include the patient experience of various aspects of the oncological journey, with particular emphasis on using these experiences to inform the role of new therapies in clinical practice. His major research interest lies with cancer associated thrombosis, particularly in advanced disease. He has experience in clinical trials, qualitative research, guideline development, and biomarker development. He is Medical Director for Thrombosis UK and chairs the All Wales Hospital Acquired Thrombosis Steering Committee.Patricia A. Parker is a psychologist, researcher and educator. She is an attending psychologist and member in the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center, NY, USA. She is Director of the Communication Skills Training and Research Program (Comskil) at MSK. The Comskil Program offers tailored, evidence-based, and interactive trainings to meet the specific communication needs of a wide variety of clinicians including attendings, fellows, residents, advanced practice providers (for example nurse practitioners and physician assistants) and ambulatory and inpatient nurses. Comskil is dedicated to improving cancer care through strengthened empathic communication between patients, families, and the care team. Dr. Parker's research primarily focuses on healthcare practitioner-patient communication and decision making and quality of life among different cancer patient populations.Susie Wilkinson holds an MSc and PhD in Cancer and Palliative Care from the University of Manchester. She worked clinically in cancer and palliative care for many years before founding and directing the first Marie Curie Palliative Care Research Unit at UCL where she led pioneering studies in end-of-life care. Dr Wilkinson has researched, published, and taught widely on palliative care including communication skills, complementary therapies, and the development of the 10/40 Model for delivering optimal care for dying patients. She was a founder and national lead for the NHS Advanced Communication Skills Training programme, Connected, which equipped cancer and palliative care professionals across England with evidence-based communication techniques. She is Executive Director of the Centre for Communication Skills and International Liaison Lead for the International Collaborative for Best Care for the Dying Person, as well as an Honorary Fellow at the Palliative Care Unit, University of Liverpool.